Status:
RECRUITING
Evaluating Replacement of Standard-of-care Low Dose Computer Tomography (CT) Scans With Radiation-free Bone Imaging by Deep-learning Augmented Zero Echo Time (DL-ZTE) Magnetic Resonance Tomography (MRT)
Lead Sponsor:
Roman Guggenberger
Conditions:
Joint Diseases
Joint Inflammation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to determine how effectively bone structures of the human skeleton can be visualized using Deep Learning (DL) augmented Magnetic Resonance Imaging (MRI) in individua...
Eligibility Criteria
Inclusion
- Referral for a clinically indicated MRI examination of the musculoskeletal system to assess inflammatory and degenerative joint changes.
- Willingness to sign the informed consent form.
- No contraindications for a CT examination (e.g., claustrophobia).
Exclusion
- No signed informed consent form.
- Patients under 18 years of age.
- Pregnant women.
- The calculated effective dose of the CT examination exceeds 5 mSv.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06579547
Start Date
August 1 2024
End Date
July 1 2026
Last Update
August 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091